Introduction Turkey operates a reimbursement system that is a critical component of the healthcare sector, aimed at ensuring patients’ access to essential medicines through public funding mechanisms. The Social Security Institution (SGK) manages this system by negotiating prices and determining which medicines are covered. For foreign pharmaceutical companies, understanding and adapting to this framework is […]